Zobrazeno 1 - 10
of 324
pro vyhledávání: '"M. Wernli"'
Autor:
Bodo, M. Wernli. E., Gianturco, F. A.
The low-temperature (up to about 100K) collisional (de)excitation cross sections are computed using the full coupled-channel (CC) quantum dynamics for both Li$_2$ and Li$_2^+$ molecular targets in collision with $^4$He. The interaction forces are obt
Externí odkaz:
http://arxiv.org/abs/0707.1832
Publikováno v:
Swiss Medical Weekly, Vol 134, Iss 3940 (2004)
Externí odkaz:
https://doaj.org/article/f9c4a6dc0d7c44b2a304e1f627b1df33
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M. Wernli, N. Borodin, Elena Zubcov, Mariska Ronteltap, Boris Boincean, Piet N.L. Lens, N. Bagrin, Nadejda Andreev
Publikováno v:
Journal of environmental management. 198(Pt 1)
During storage of urine, urea is biologically decomposed to ammonia, which can be lost through volatilization and in turn causes significant unpleasant smell. In response, lactic acid fermentation of urine is a cost-effective technique to decrease ni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::123fd863cd7e2347045cc3a7a1737d29
https://pubmed.ncbi.nlm.nih.gov/28448847
https://pubmed.ncbi.nlm.nih.gov/28448847
Autor:
David L. B. Schwappach, M. Wernli
Publikováno v:
Journal of Clinical Oncology. 28:2896-2901
Purpose To explore chemotherapy patients' experiences of drug administration safety and to investigate the relationship between perceptions of risk and harm from error, staff safety practices, and patients' engagement in error prevention strategies.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c48fa15f3506b4e9745f36c44e2dfcc4
https://doi.org/10.1200/jco.2009.27.6626
https://doi.org/10.1200/jco.2009.27.6626
Autor:
M. Wernli, David L. B. Schwappach
Publikováno v:
European Journal of Cancer Care. 19:285-292
Medication errors in chemotherapy occur frequently and have a high potential to cause considerable harm. The objective of this article is to review the literature of medication errors in chemotherapy, their incidences and characteristics, and to repo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10d2ebe02465cd95c39922f583e7205d
https://doi.org/10.1111/j.1365-2354.2009.01127.x
https://doi.org/10.1111/j.1365-2354.2009.01127.x
Publikováno v:
Oncology Nursing Forum. 37:E84-E91
To explore oncology nurses' perceptions and experiences with patient involvement in chemotherapy error prevention.Qualitative descriptive study.In- and outpatient oncology units of a community hospital in Switzerland.11 actively practicing oncology n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64bea71816bfef63979976ce6ecfcb75
https://doi.org/10.1188/10.onf.e84-e91
https://doi.org/10.1188/10.onf.e84-e91
Autor:
Michael Pfreundschuh, Thomas Geer, Matthias Edinger, H Hebarth, Karsten Spiekermann, Antonio Pezzutto, Andreas Hochhaus, Jörg Thomalla, Joerg Hasford, Lorenz Trümper, Sebastien Rinaldetti, M. de Wit, Martin Bentz, Christof Scheid, Rudolph Schlag, Hans-Jochem Kolb, Walter Verbeek, M Hahn, Christoph Nerl, Hans-Walter Lindemann, Peter Brossart, Frank Stegelmann, C. Falge, Mathias Hänel, Susanne Saussele, Claus-Henning Köhne, Leopold Balleisen, Claudia Haferlach, F. Schlegel, Dieter K. Hossfeld, Lutz P. Müller, Stefan W. Krause, Rüdiger Hehlmann, Cornelius F. Waller, Hartmut Link, C. A. Köhne, Bernd Hertenstein, E. Schäfer, Tim H. Bruemmendorf, Birgit Spiess, Lothar Kanz, Astghik Voskanyan, Philippe Schafhausen, Michael Schenk, R. Fuchs, Anthony D. Ho, Andreas Neubauer, Markus Pfirrmann, Wolfgang Seifarth, Wolfgang E. Berdel, Katharina Kohlbrenner, Jiri Mayer, Winfried Gassmann, Alice Fabarius, Jolanta Dengler, Maria Elisabeth Goebeler, Michael J. Eckart, Ulrike Proetel, Andreas Burchert, Michael Lauseker, Brigitte Schlegelberger, Dietrich W. Beelen, Alois Gratwohl, Gabriela M. Baerlocher, Dominik Heim, Michael Kneba, Martin C. Müller, S. Bildat, Sabine Jeromin, M. Wernli
Publikováno v:
Blood. 130:897-897
Background Chronic myeloid leukemia (CML)-study IV was designed to explore whether treatment with imatinib (IM) at 400mg/day (n=400) could be optimized by doubling the dose (n=420), adding IFN (n=430) or cytarabine (n=158) or using IM after IFN-failu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23f76b4cd2daeb18c79c0abd58606cde
https://doi.org/10.1182/blood.v130.suppl_1.897.897
https://doi.org/10.1182/blood.v130.suppl_1.897.897
Publikováno v:
Leukemia & Lymphoma. 51:149-152
Bendamustine was designed as a bifunctional anticancer compound combining an alkylating and an antimetabolite function. It shows unique mechanisms of action and incomplete cross resistance to other...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d5721978a45b60ea561cb8ab110d8b0
https://doi.org/10.3109/10428190903275602
https://doi.org/10.3109/10428190903275602
Publikováno v:
International Journal of Mass Spectrometry. 280:57-64
The fully three-dimensional ground and first electronically excited states of the [LiHHe]+ system were computed with ab initio methods, using a self-consistent field treatment followed by a multi-reference configuration interaction calculation. The t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e43299f71f81634024347ca31566d1c5
https://doi.org/10.1016/j.ijms.2008.07.019
https://doi.org/10.1016/j.ijms.2008.07.019